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High-pressure(HP)biotechnologyisanemergingtechniqueinitiallyappliedforfoodprocessingandmorerecentlyinpharmaceutical
and medical sciences. Pressure can stabilize enzymes and modulate both their activity and speciﬁcity. HP engineering of proteins
may be used for enzyme-catalyzed synthesis of ﬁne chemicals, pharmaceuticals, and production of modiﬁed proteins of medical or
pharmaceuticalinterest.HPinactivationofbiologicalagentsisexpectedtobeapplicabletosterilizationoffragilebiopharmaceuticals,
or medical compounds. The enhanced immunogenicity of some pressure-killed bacteria and viruses could be applied for making
newvaccines.Finally,storageatsubzerotemperatureswithoutfreezingisanotherpotentialapplicationof HPforcells,animaltissues,
blood cells, organs for transplant, and so forth.
INTRODUCTION
Pressure is an important environmental parameter. More
than 70% of the Earth’s surface is covered by oceans (average
hydrostatic pressure: 0.4kbar (The ofﬁcial pressure unit (SI)
is Pascal (Pa): 1bar = 105 Pa), where abyssal organisms are
adapted to pressure and low temperatures (1◦C–3◦C). Those
livingclosetohydrothermalvents,wherethetemperaturecan
behigherthan100◦C,arehyperthermophilesadaptedtohigh
pressure. Enzymes of these organisms, called extremozymes,
have potential biotechnological applications. Lessons from
natural extremozymes should help to design stable mutants
of mesophilic enzymes capable of working with enhanced
catalytic efﬁciency under extreme conditions of pressure and
temperature. The observation that pressure can inactivate
barosensitive microorganisms, and the dramatic effects of
pressureonmacromolecularsystemsareattheoriginofhigh-
pressure biotechnology born in Japan the early 90s where it
has been ﬁrst applied to food preservation and processing
[1–3]. Now this emerging technology has reached maturity,
and its sphere of application is growing up. The purpose of
this review is to stress potential pharmaceutical and medical
applications of high-pressure biotechnology.
EFFECTS OF PRESSURE ON CONSTITUENTS
OF LIVING MATTER
These effects have been extensively reviewed in recent
years [1–5]. The behavior of biosystems under high hydro-
static pressure is governed by Le Chateliers’ principle, which
predicts that pressure favors processes accompanied by neg-
ative volume changes, and conversely, inhibits processes ac-
companied by positive volume changes.
In the pressure range of biotechnological interest, pres-
sure has, in general, no effect on covalent bonds. Therefore,
natural compounds such as ﬂavors, aromas, dyes, and phar-
macologically active molecules are not destroyed by high-
pressuretreatmentatroomtemperature.Severalprovitamins
and vitamins (β-carotene, thiamin, riboﬂavin, folic acid,
ascorbate, retinol, tocopherol)have been found to resist to
pressures as high as 6–8kbar. Cycloadditions such as Diels-
Alder reactions, accompanied by large volume contractions,
are accelerated by pressure. It was shown that these reactions
couldpromotethedestructionofvitaminsKandcoenzymeQ
at elevated pressure (6.5kbar)and temperature (70 ◦C).
Pressure acts also on the structure of membranes, bio-
polymers, and multimacromolecular assemblies because of
actionsonnoncovalentbonds.Hydrophobicinteractions,the
most important weak bonds involved in the stability of pro-
teins,micelles,andlipidsaredifferentiallyalteredbypressure.
Formationofhydrogenbondsisassociatedwithsmallvolume
contractions and reinforced under pressure. Ionic bonds are
disrupted by pressure. Ionization of acids, bases, salts, and
self-ionization of water is increased under pressure. Nucleic
acidsandpolysaccharidesarepressure-resistantbecausetheir
secondary structure is mainly stabilized by H-bonds that are
almost pressure insensitive. Proteins are the most pressure
sensitive biomolecules [5, 6], as it will be shown in the fol-
lowing sections.
PRESSURE DENATURATION
Likeheating,pressurecandenatureproteins.Pressurede-
naturation is a complex multistep process, depending on the
pressure range, the rate of compression and the exposure86 Patrick Masson et al. 1:2 (2001)
time to pressure. Studies of protein temperature-pressure
dependence showed elliptic phase diagrams [5]. Pressures
lower than 3kbar inactivate enzymes but do not cause ex-
tensive conformational changes in protein structures. More-
over,in some cases,there is evidence that moderate pressures
induce conformational transitions toward compact partially
unfolded states called“molten globules”(MG)[7].
Theformationof homogeneousproteingels,polysaccha-
ride gels, and protein-polysaccharide mixed gels under pres-
sure is of great interest in cosmetology and pharmaceutical
applications. Pressure gels and ﬂocculated emulsions of pro-
teinscanbeusedfortheirparticularrheologicalpropertiesor
as carriers for the slow-release of trapped active compounds.
Studyoftheeffectsofpressureonthermoresponsivesynthetic
polymersshouldhelptomasterthecontrolledassaytimes.Fi-
nally, application of pressures around 2kbar has been used
forreversingaggregationof misfoldedproteinsandinclusion
bodies, and increasing proper refolding. This has been suc-
cessfully applied to recombinant proteins of pharmaceutical
interest.
CHEMICAL MODIFICATIONS OF PROTEINS
AND OTHER MACROMOLECULES
Proteins can be chemically modiﬁed under pressure to
link aromatic groups. This leads to easily emulsiﬁable pro-
teins. Interestingly, the formation of brownish melanoidines
is pressure-inhibited. The Diels-Alder addition reaction can
be used for the chemical modiﬁcation of proteins or for se-
lective bioimmobilization of proteins and biologically active
molecules. Such adducts could be used as drug delivery sys-
tems or as biological components in biosensors.
Enzymemodiﬁcationofproteinsandpolysaccharidescan
be achieved under pressure. In particular,pressure can mod-
ulate enzyme activity such as the speciﬁcity of proteases. The
partial proteolysis of milk proteins has been applied to in-
crease their digestibility [1].
ENZYME-CATALYZED CHEMICAL REACTIONS
Enzyme reactions under high pressure or in supercritical
CO2 are a new and promising aspect of enzyme engineering
[8, 9]. The enzyme-catalyzed synthesis of pharmaceuticals
under mild conditions has proved to be possible. In particu-
lar, the enantioselective synthesis of esters such as ibuprofen
esteriﬁcation by lipases, pharmacological peptides by ther-
molysin[10],polyols,andsweetenersseemstobeinteresting.
These reactions are performed in bioreactors at pressures, in
general,lower than 2kbar,i.e.,pressures that do not alter the
stability and functionality of enzymes. By operating in the
presence of stabilizing cosolvents or in organic media, it can
be possible to increase the thermobarostability of industrial
enzymes [11].
Pressure can be turned to account to promote reactions
catalyzed by naturally occurring enzymes in plant cells. For
instance, pressure was found to favor the hydrolysis of glu-
cosynolates of cruciferous plants. This leads to bioactive
isothiocynates. Glucoraphanin from broccoli juice can be
converted to sulforaphane,which displays antitumor activity
and nematocidal properties [12]. Such reactions can be used
forfoodfunctionalizationandforproducing“nutraceuticals”
to be used in complementary therapy.
The high-pressure processing could be used for the stabi-
lizationof heatlabileneutraceuticalsinnaturalproducts,e.g.,
vitamins.Moreover,theantimutagenicpotenciesof vegetable
juices,presumablyduetoperoxidaseactivities,areonlypartly
reducedbypressuresfrom6to8kbar,forcarrots,cauliﬂower,
kohlrabi, leek, spinach, beet, and tomatoes. The anticarcino-
genic activities of these vegetable juices are more or less heat
sensitive but they are resistant to a pressure of 4kbar at room
temperature, a pressure industrially used for stabilization of
low acid products.
Pressure processing was found to be efﬁcient to reduce
the allergenic activity of food. One of the three known aller-
genicstructuresofceleryrootisdestroyedat6kbarand20◦C.
The Echigo-Seika company has been marketing for several
years a hypoallergenic precooked rice. This patented process
applicable to rice could also be used for wheat and barley
processing [13].
PRESSURE-ASSISTED FREEZING ANDTHAWING
AND STORAGE AT SUBZEROTEMPERATURE
WITHOUT FREEZING
Thesolid-liquidphasediagramofwatershownthatwater
remainsliquiddownto −20◦Cunderapressureof 2kbar[4].
Severalapplicationsoftheeffectofhighpressureonthephase
transitions of water are currently under development in food
technologyandmorerecentlyforpossibleapplicationsforthe
preservation of biopharmaceuticals, blood derivatives, cells,
andorgansfortransplant.A1960studyshowedthatpressure-
assisted thawing could improve the survival rate of slowly
frozen human conjunctiva and chick skin cells [14].
Thefreezinginductionofaproductcooledattemperature
from −10◦Ct o−20◦C under a pressure of 1kbar to 4kbar
is quite instantaneous when pressure is release. Less struc-
tural damages are noticed for products frozen with the help
of pressure than with −30◦C air or with liquid nitrogen at
atmosphericpressure.Thistechniquehasbeenusedforcryo-
ﬁxationof samplesforelectronmicroscopy.Itcouldprobably
allow fragile biopharmaceutical products to be frozen with-
out damage.
The properties of water under pressure allow also bio-
products to be stored at subzero temperature without freez-
ing. The process (an increase of pressure up to 1–2kbar, fol-
lowed by a cooling and a reheating before depressurization)
has less dramatic effects than freezing and thawing processes.
The contaminating microorganisms and spoiling enzymes
are reduced during this subzero temperature nonfrozen
storage.
INACTIVATION OF BIOLOGICAL AGENTS
High pressure causes inactivation of vegetative microor-
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key enzymes,and inhibition of protein biosynthesis [15].Al-
though some bacterial strains are known to resist at pres-
sures higher than 8kbar [16], the combined action of
pressure and moderate heat could be used for sterilization—
pascalization—of heat sensitive products, liposomes, cos-
metic products, and even small surgical or endoscopic tools.
Bacterial spores are very resistant to pressure. However,their
inactivationcanbeachievedbyassociatingheatand/orchem-
ical treatment with pressurization [3].
Viruses are very sensitive to moderate pressures between
1 and 3kbar [17]. Inactivation of numerous viruses such as
herpesvirusesandimmunodiﬁciencyviruses[18]bypressure
has been successful. Combining pressure, low temperature,
and urea can facilitate the disassembly of viruses. Among
possible applications are inactivation of viruses in biologi-
cal compounds, sterilization of biological materials, blood,
and tools. The use of high pressures in decreasing the virus
concentration in blood of patients suffering severe virus in-
fections such as AIDS by ex vivo pressure treatment of blood
has also been proposed.
Nonconventionalagents,i.e.,misfoldedisoforms(scrapie,
PrPsc)of cellular prion proteins (PrPc) ,are very stable. They
can resist treatment at 160◦C for up to 24hours. However,
preliminary results showed that the prion protein responsi-
ble for the Syrian hamster spongiform encephalopathy can
be inactivated by pressures higher than 5kbar (Cléry, Mas-
son, Dormont, unpublished data, 2000). However, complete
and safe inactivation of prion proteins would probably need
application of pressures higher than 10kbar, which preclude
practical use with commercially available equipments.
DEVELOPMENT OFVACCINES
Pressure-induced unfolding of proteins unmasks anti-
genic sites and may increase immunogenic properties of
pressure treated proteins,killed viruses and microorganisms.
Basset and colleagues at the Paris Institute Pasteur carried
out ﬁrst researches on the use of pressure to make vaccinal
proteins. In mid-ﬁfties, a vaccine against polyomyelitis was
almost ready [19]. For economic reasons, these works ended
quickly, after the Sabin vaccine was launched on the market.
In the past few years, pressure has regained interest in the
development of vaccines against viruses and malignant cells.
In particular, inactivation of Rift valley fever virus (RVFV)
at 2.75kbar/25◦C in 30min showed that the immunogenetic
capabilityofpressure-inactivatedviralparticlesishigherthan
that of formaldehyde-treated virus; mice which were vacci-
nated with pressure-treated virus were protected against in-
fection by wild-type RVFV [20].
CONCLUSION
High-pressure bioscience is now a ﬁeld that is growing
up. In addition to the increasing number of basic publica-
tions and international conferences,very active international
HP networks are building up. This is stimulating because the
development of the HP biotechnology requires knowledge
in many scientiﬁc and technological ﬁelds, from physics to
medicine through biology, chemistry, and material sciences.
In a very near future, it can be expected that a better under-
standing of the pressure effects on biomolecules and living
cells will permit progress and development of the HP tech-
nology in medicine and pharmacy.
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